Tudor Investment Corp’s Amicus Therapeutics FOLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$914K Buy
159,497
+88,206
+124% +$505K ﹤0.01% 1128
2025
Q1
$582K Sell
71,291
-77,577
-52% -$633K ﹤0.01% 1185
2024
Q4
$1.4M Buy
148,868
+514
+0.3% +$4.84K 0.01% 885
2024
Q3
$1.58M Buy
+148,354
New +$1.58M 0.01% 854
2023
Q2
Sell
-133,697
Closed -$1.48M 1686
2023
Q1
$1.48M Buy
133,697
+79,120
+145% +$878K 0.02% 759
2022
Q4
$666K Buy
+54,577
New +$666K 0.01% 1020
2021
Q4
Sell
-12,579
Closed -$120K 1770
2021
Q3
$120K Buy
+12,579
New +$120K ﹤0.01% 1461
2021
Q2
Sell
-63,292
Closed -$625K 1590
2021
Q1
$625K Buy
63,292
+17,150
+37% +$169K 0.01% 1038
2020
Q4
$1.07M Buy
46,142
+30,546
+196% +$705K 0.03% 665
2020
Q3
$220K Buy
+15,596
New +$220K 0.01% 1105
2020
Q1
Sell
-49,156
Closed -$479K 1139
2019
Q4
$479K Buy
49,156
+18,851
+62% +$184K 0.02% 727
2019
Q3
$243K Sell
30,305
-186,971
-86% -$1.5M 0.01% 904
2019
Q2
$2.71M Buy
+217,276
New +$2.71M 0.08% 225
2019
Q1
Sell
-79,495
Closed -$762K 1137
2018
Q4
$762K Buy
79,495
+42,898
+117% +$411K 0.02% 469
2018
Q3
$442K Sell
36,597
-6,127
-14% -$74K 0.01% 714
2018
Q2
$667K Buy
+42,724
New +$667K 0.02% 569
2017
Q3
Sell
-12,332
Closed -$124K 1130
2017
Q2
$124K Buy
+12,332
New +$124K ﹤0.01% 938
2017
Q1
Sell
-51,290
Closed -$255K 1422
2016
Q4
$255K Buy
+51,290
New +$255K 0.01% 1074
2016
Q3
Sell
-72,981
Closed -$398K 1466
2016
Q2
$398K Buy
72,981
+56,031
+331% +$306K 0.01% 845
2016
Q1
$143K Buy
+16,950
New +$143K ﹤0.01% 1331
2015
Q4
Sell
-38,735
Closed -$542K 1556
2015
Q3
$542K Sell
38,735
-67,621
-64% -$946K 0.02% 675
2015
Q2
$1.51M Buy
106,356
+94,736
+815% +$1.34M 0.04% 253
2015
Q1
$126K Sell
11,620
-86,902
-88% -$942K ﹤0.01% 1347
2014
Q4
$820K Buy
98,522
+20,443
+26% +$170K 0.03% 437
2014
Q3
$465K Buy
+78,079
New +$465K 0.02% 709